Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
The 21st century:
The era of precision medicine
Dr. Henk Joos
01.06.2017
Helsinki
From Mass Disease treatment model to novel Precision Health Management
Prevention Diagnosis Treatment Care
A patient driven journey in novel precision health management
Mass Treatment Drug companies Doctors Patients
Hospitals
Multiple
dimensions in
novel health
management
Life
Sciences
Drive
Technology
Drive
Disease
Focus
Disease focus Oncology
Inflammation and Immune
diseases
CNS
Infectious diseases
Technology Drive Nano electronics
ICT and smart data
3D printing
Mechatronics
Life Sciences Drive Vaccinology and Immunology
Microbiome
Regenerative Medicine
Life
Sciences
Drive
Technology
Drive
Flanders is a key player in precision medicine
Disease
Focus
Flanders as one of the EU catalyzers
Life
Sciences
Drive
Technology
Drive
Disease
Focus
C3-SAXONY –
CROSSCLUSTER COOPERATION IN SAXONY
Flanders as one of the EU catalyzers
Life
Sciences
Drive
Technology
Drive
Disease
Focus
Cover the entire value chain
o Basic > applied > translational
research
o Create a business environment
o Combine knowledge and
technologies
o Realise step-changes for
patients: prevention & cure &
care
o Accessible & affordable
treatments
7 November 2016 LoI
o Flanders – the Netherlands top
in Ghent
RegMed XB – a case example for smart specialisation
Building a regeneration core in Europe: the ongoing step
www.regmed.be
Key hurdles for Precision Medicine
Multi-disciplinary Talent
Regulatory systems not up to date and founded in different worlds (life sciences vs technology)
Need for new collaboration and business models
Empowerment of Innovation through SME’s
Engagement of patients and society at large (e.g. human sample foundation for scientific purposes)
Financing of SME’s and academic research Seed financing
Product and service delivery financing
Multi-disciplinary collaboration is key